Maintain residual position through Oct 1 binary catalyst; $32.50 stop binding, no pre-print adds or trims
HOLD is the lowest expected-regret posture: the Research Manager, Trader, Conservative Analyst, and Neutral Analyst all converge on passive maintenance; the binding 9/22-9/23-9/24 NKE sequence resolves the Aggressive Analyst's outlier ADD proposal. Pre-committed post-print framework anchors decisions: bull print → upgrade to $48-50 overweight; base print → maintain and reassess; bear print → exit to $28-30 zero. The $32.50 close-based stop (~1.5 ATR below $34.05) is binding; mechanical discipline applies (one trigger, no triple-confirmation, no averaging in, no adjustment for noise).
| Position | Action |
|---|---|
| Current architecture (post-9/22 40% trim) | Maintain residual 60% unhedged position with no changes |
| Income accounts | Hold for 4.56% dividend yield ($9B cash, near-zero net debt cushion intact) |
| Capital-growth accounts | Stay at maintenance weight; do not initiate new capital deployment |
| Aggressive Analyst pre-print ADD proposal | Reject—fails 9/11/9/15/9/16 binding lessons on adding into cushioned-compounder binary catalysts |
| Fresh trim / Underweight re-trim | Reject—9/23 reflection is dispositive: post-trim re-trimming bleeds alpha; whipsaw architecture warned against |
| Full exit / Sell | Reject—surrenders $9B cash floor, 4.56% yield carry, and convexity on neutral-to-positive print |
Nike's Q4 FY2026 gross margin print of 49.1% (890bps sequential expansion) confirms an earnings inflection that makes BofA's $30 price target thesis obsolete; the stock at $35.75 trading at 16.17x forward P/E with a 4.56% yield, fortress balance sheet ($9B cash, $0.38B net debt), and extreme bearish sentiment (2.8/10) creates asymmetric upside with $48–$55 targets versus $33.20 stop.
| Indicator | Value | Signal |
|---|---|---|
| Close | $35.75 | bearish |
| 10 EMA | 36.24 | bearish |
| 50 SMA | 39.41 | bearish |
| 200 SMA | 48.61 | bearish |
| RSI (14) | 35.57 | bearish |
| MACD | -1.06 | bullish |
| MACD Signal | -1.09 | bullish |
| MACD Histogram | +0.03 | bullish |
| Bollinger Upper | 39.43 | neutral |
| Bollinger Middle | 37.06 | neutral |
| Bollinger Lower | 34.69 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Upgrade residual to Overweight, target $48-50
NKE at $35.75 is historically undervalued — trading at 16.17x forward P/E versus its own 10-year average of 27x, with Lululemon at 20–25x and Deckers (Hoka parent) at 25x+
↩ rebuts: “The claim that Nike is expensive at $35 ignores that 16x P/E represents a trough multiple vs historical averages”
EV: +38.5% to +53.8% (targets of $48–$55 vs entry at $35.75) · concedes: BofA's $30 price target is acknowledged but dismissed as backward-looking thesis built on depressed earnings through FY2027; Technical setup is bearish (10 EMA < 50 SMA < 200 SMA, lower-low pattern, elevated volatility) — these are conceded; China weakness, wholesale contraction, and FY28 recovery timeline are real risks but already priced in at $35.75; The stock has declined from early-2026 highs and is near 52-week lows; RSI at 35.57 hasn't yet reached capitulation levels
Nike is a high-quality business in genuine multi-year structural decline; the Q4 margin "inflection" is an anomaly, the valuation discount reflects correct market assessment of earnings stagnation, and the asymmetry favors the bear as the "merely OK" scenario produces only a small bounce while disappointment produces 15-20% downside to $28-30.
· concedes: The MACD did cross (by 0.03); Moving averages are in bearish configuration; Bollinger lower band at $34.69 does historically correlate with reversals; High dividend yield exists; Brand isn't dead — moat is intact but narrowing; Not shorting NKE into binary catalyst due to squeeze risk; Hill may be the right leader eventually; One-quarter anomaly could become a trend with evidence in Q2 FY27
→ vs conservative: FCF coverage at 0.91x and OCF collapsing 61% are not balance sheet stress but absorption of shock with $9B cash and zero net debt at $380M; working capital headwind from AR rising 26% signals wholesale restocking, not demand deterioration
→ vs conservative: The four bull conditions are not independent—they cascade: Q4 already delivered margin expansion, China stabilization follows revenue stabilization, multiple expansion follows margin sustainability; bears need ALL four to fail
→ vs conservative: BofA Underperform at $30 is based on FY2027+ contraction but Q4 FY26 inflection proves their timeline wrong; consensus capitulation at 2.8 sentiment creates contrarian opportunity
→ vs conservative: Protective puts strategy giving up 30% of upside for capped downside is 'free-option-collector mindset' not aggressive positioning; correct sizing is to build ahead of catalyst with disciplined $33.20 stop
→ vs neutral: Technical bearish stack (10 EMA below 50 SMA below 200 SMA) ignores MACD bullish crossover, histogram positive at plus 0.03, and price at Bollinger lower band reversal zone
→ vs neutral: Confirmation-seeking after $40 peak-to-trough decline is how you miss bottoms; Nike 2017 and Apple 2019 both rewarded early entries over confirmation waiters
→ vs neutral: Bearish macro (10-year at 2007 highs, 97% no Fed cuts odds) actually creates bid for 4.56% yielding, fortress balance sheet turnaround story; cyclical headwinds differ from structural deterioration
| ATR | 0.97 | neutral |
| VWMA | 36.43 | bearish |
Support: 34.69 · 34 · 32 | Resistance: 36.24 · 37.06 · 39.41 · 39.43 · 40.62 · 43.34 · 48.61
NKE is in a structural downtrend with price at $35.75, down approximately 46% from the January 2026 peak near $64 and 26.5% below the 200 SMA at $48.61. The 10 EMA ($36.24), 50 SMA ($39.41), and 200 SMA ($48.61) are in perfect bearish alignment with each tested rally failing at the 50 SMA. Volume has been heavy on down days (e.g., 114M on April 1, 2026 gap-down; 52M on September 18), confirming seller control. While the MACD has produced a marginal bullish crossover and the histogram flipped positive for the first time in months, these signals occur at deeply negative levels and should not be treated as standalone buy signals. The ATR of 0.97 indicates elevated volatility (~2.7% daily range), warranting wider position sizing. Price is currently testing the Bollinger lower band at $34.69; a breakdown below this level would likely accelerate downside to the $32.00-$34.00 target zone, while a reclaim of the mid-band at $37.06 would be the first constructive short-term signal. The overall recommendation is HOLD with no confirmed reversal signal present.
Market Cap
$53.04 B
Share Price (derived)
~$35.76
PE Ratio (TTM)
17.02x
Forward PE
16.17x
PEG Ratio
1.41
Price/Book
3.57x
EPS (TTM)
$2.10
Forward EPS
$2.21
Dividend Yield
4.56%
Beta
1.11
52-Week High
$76.97
52-Week Low
$35.22
50-Day MA
$39.86
200-Day MA
$49.63
Book Value/Share
$10.02
Revenue (FY2026)
$46.40B
Gross Profit (FY2026)
$19.91B
Gross Margin (FY2026)
42.9%
Operating Income (FY2026)
$3.80B
Net Income (FY2026)
$3.11B
Diluted EPS (FY2026)
$2.10
Revenue vs Peak
-10%
Operating Margin (TTM)
12.7%
Net Profit Margin (TTM)
6.7%
ROE
22.1%
ROA
7.0%
Cash & ST Investments
$9.03B
Total Assets
$38.41B
Inventory
$7.50B
Accounts Receivable
$5.93B
Total Debt
$11.03B
Long-Term Debt
$5.94B
Stockholders' Equity
$14.87B
Net Debt
$0.38B
Current Ratio
1.96
Debt-to-Equity
0.74
Operating Cash Flow (FY2026)
$2.87B
CapEx (FY2026)
$684M
Free Cash Flow (FY2026)
$2.18B
Dividends Paid (FY2026)
$2.41B
Share Repurchases (FY2026)
$146M
Share Count Change (3yr)
-5.7%
FCF/Dividend Coverage
0.91x
Q4 FY2026 Revenue
$10.97B
Q4 FY2026 Gross Margin
49.1%
Q4 FY2026 EPS
$0.72
Q4 FY2026 Operating Income
$1.31B
Strengths
Concerns
NIKE is in the middle of a multi-year brand and margin reset, with revenue declining ~10% from its FY2024 peak of $51.36B to $46.40B in FY2026, and net income roughly halved from $5.7B to $3.1B. The financial position remains strong with $9.03B cash, near-zero net debt, and a healthy 22.1% ROE, while the 4.56% dividend yield offers income appeal. However, Q4 FY2026's 49.1% gross margin and 5x EPS recovery signal early improvement, and revenue growth and margin recovery are not yet confirmed — trends have not turned bullish, warranting a measured HOLD posture with potential upgrade to BUY upon confirmation of stabilization.
Macro: 10Y Treasury at highest level since 2007; 30Y at highest since 2004; Wall Street bracing for additional Fed rate hikes (not cuts); mortgage rates approaching 7.5%; prediction markets pricing 97% probability of NO Fed cuts in 2026; only 10% odds of US recession by end of 2026; housing affordability at multi-decade lows; equity markets (Dow, S&P 500, Nasdaq) posted weekly gains despite bond rout — risk-on in equities but defensive within sectors; consumer cyclicals are laggards; Iran/Hormuz tensions flagged by JPMorgan adding to input-cost uncertainty.